Table 11.
Key performance indicators | Total | Female | Male | |||
Relative frequency | % (95% CI) | Relative frequency | % (95% CI) | Relative frequency | % (95% CI) | |
DVT prophylaxis | 413/1762 | 23.4 (21.5 to 25.4) | 155/668 | 23.2 (20.0 to 26.4) | 258/1094 | 23.6 (21.1 to 26.1) |
Dysphagia screen | 2048/3002 | 68.2 (66.6 to 69.9) | 795/1160 | 68.5 (65.9 to 71.2) | 1253/1842 | 68.0 (65.9 to 70.2) |
Rehabilitation | 1765/3002 | 58.8 (57.0 to 60.6) | 690/1160 | 59.5 (56.7 to 62.3) | 1075/1842 | 58.4 (56.1 to 60.6) |
BP lowering for HTN | 1374/1876 | 73.2 (71.2 to 75.2) | 509/710 | 71.7 (68.4 to 75.0) | 865/1166 | 74.2 (71.7 to 76.7) |
Glucose-lowering for hyperglycaemic | 199/314 | 63.4 (58.1 to 68.7) | 71/112 | 63.4 (54.5 to 72.3) | 128/202 | 63.4 (56.7 to 70.0) |
Smoking cessation | 351/377 | 93.1 (90.6 to 95.7) | 331/354 | 93.5 (90.9 to 96.1) | 20/23 | 87.0 (73.2 to 100) |
Summary performance measures | ||||||
Composite score | 0.60±0.31 | 0.62±0.31 | 0.59±0.31 | |||
All-or-none measure | 712/3002 | 23.7 (22.2 to 25.2) | 288/1160 | 24.8 (22.3 to 27.3) | 424/1842 | 23.0 (21.1 to 24.9) |
BP, blood pressure; DVT, deep vein thrombosis; HTN, hypertension.